These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 21752736)

  • 21. Assessment of gastro-oesophageal reflux symptoms in Italian physicians -- a survey by Reflux Disease Questionnaire.
    Pace F; Molteni P; Casini V; Pallotta S; Bianchi Porro G
    Dig Liver Dis; 2008 Apr; 40(4):235-9. PubMed ID: 18243076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Raghunath AS; Hungin AP; Mason J; Jackson W
    Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
    Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of gastro-oesophageal reflux disease in general practice].
    Hollenz M; Stolte M; Labenz J
    Dtsch Med Wochenschr; 2002 May; 127(19):1007-12. PubMed ID: 11997867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antireflux surgery for non-erosive and erosive reflux disease in community practice.
    Thibault R; Coron E; Sébille V; Sacher-Huvelin S; Bruley des Varannes S; Gournay J; Galmiche JP
    Aliment Pharmacol Ther; 2006 Aug; 24(4):621-32. PubMed ID: 16907894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
    Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
    Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran.
    Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
    Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does laparoscopic antireflux surgery improve quality of life in patients whose gastro-oesophageal reflux disease is well controlled with medical therapy?
    Gillies RS; Stratford JM; Booth MI; Dehn TC
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):430-5. PubMed ID: 18403945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease.
    Hsu CS; Wang PC; Chen JH; Su WC; Tseng TC; Chen HD; Hsiao TH; Wang CC; Lin HH; Shyu RY; Chao YC
    Aliment Pharmacol Ther; 2011 Oct; 34(8):994-1004. PubMed ID: 21848629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study.
    Wong WM; Lai KC; Lam KF; Hui WM; Huang JQ; Xia HH; Hu WH; Lam CL; Chan CK; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2004 Oct; 20(7):803-12. PubMed ID: 15379841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of proximal gastro-oesophageal reflux in patients with rhonchopathy and sleep apnoea].
    Esteller More E; Huerta Zumel P; Modolell Aguilar I; Segarra Isern F; Matiñó Soler E; Enrique González A; Ademà Alcover JM
    Acta Otorrinolaringol Esp; 2007 Dec; 58(10):464-9. PubMed ID: 18082076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
    Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
    Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep-related breathing disorders in small children with nocturnal acid gastro-oesophageal reflux.
    Wasilewska J; Kaczmarski M
    Rocz Akad Med Bialymst; 2004; 49():98-102. PubMed ID: 15631322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population.
    Cheung TK; Lam KF; Hu WH; Lam CL; Wong WM; Hui WM; Lai KC; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2007 May; 25(9):1099-104. PubMed ID: 17439511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
    Fujiwara Y; Habu Y; Ashida K; Kusano M; Higuchi K; Arakawa T
    Digestion; 2013; 88(3):145-52. PubMed ID: 24008338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
    Ruszniewski P; Soufflet C; Barthélémy P
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1134-9. PubMed ID: 18671778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of the ALEGRIA study in Luxembourg. An epidemiological, observational study to describe symptom impact and control in patients with GERD and an evaluation of the GERD Impact Scale.
    Fritz R; Goodman N; Duquenne V; Taeter C
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (2):141-52. PubMed ID: 19999624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.